Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 3
1972 1
1973 1
1974 2
1975 1
1976 2
1977 3
1979 1
1980 1
1981 3
1982 3
1983 1
1985 3
2020 4
2021 8
2022 7
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction.
Biagioli M, Marchianò S, Roselli R, Di Giorgio C, Bellini R, Bordoni M, Gidari A, Sabbatini S, Francisci D, Fiorillo B, Catalanotti B, Distrutti E, Carino A, Zampella A, Costantino G, Fiorucci S. Biagioli M, et al. Among authors: gidari a. Biochem Pharmacol. 2021 Jun;188:114564. doi: 10.1016/j.bcp.2021.114564. Epub 2021 Apr 17. Biochem Pharmacol. 2021. PMID: 33872570 Free PMC article.
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO).
Polverino F, Stern DA, Ruocco G, Balestro E, Bassetti M, Candelli M, Cirillo B, Contoli M, Corsico A, D'Amico F, D'Elia E, Falco G, Gasparini S, Guerra S, Harari S, Kraft M, Mennella L, Papi A, Parrella R, Pelosi P, Poletti V, Polverino M, Tana C, Terribile R, Woods JC, Di Marco F, Martinez FD; ItaliCO study group. Polverino F, et al. Front Cardiovasc Med. 2020 Oct 9;7:585866. doi: 10.3389/fcvm.2020.585866. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 33195473 Free PMC article.
Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients.
Schiaroli E, Gidari A, Brachelente G, Bicchieraro G, Spaccapelo R, Bastianelli S, Pierucci S, Busti C, Pallotto C, Malincarne L, Camilloni B, Falcinelli F, De Socio GV, Villa A, Mencacci A, Francisci D. Schiaroli E, et al. Among authors: gidari a. J Clin Virol. 2023 Nov;168:105584. doi: 10.1016/j.jcv.2023.105584. Epub 2023 Sep 17. J Clin Virol. 2023. PMID: 37778220 Free article.
Pre and Post-Monoclonal Infusion Neutralizing Activity in a Subgroup of Patients Treated in the Presence of two SARS-CoV-2 Dominant Variant of Concern (VOCs) and an Ongoing Vaccination. Overall Clinical Efficacy of Two Monoclonal Antibodies Association in Umbria.
Schiaroli E, De Socio GV, Gidari A, Malincarne L, Benedetti S, Lanzi A, Bastianelli S, Pierucci S, Busti C, Fagotti B, Vicenti I, Zazzi M, Francisci D. Schiaroli E, et al. Among authors: gidari a. Mediterr J Hematol Infect Dis. 2022 Jul 1;14(1):e2022050. doi: 10.4084/MJHID.2022.050. eCollection 2022. Mediterr J Hematol Infect Dis. 2022. PMID: 35865399 Free PMC article.
51 results